相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B
Stephane Daffis et al.
HEPATOLOGY (2021)
Treatment with the Immunomodulator AIC649 in Combination with Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B
Kyle E. Korolowicz et al.
VIRUSES-BASEL (2021)
Innate immunity and HBV persistence
Carolina Chiale et al.
CURRENT OPINION IN VIROLOGY (2021)
Application of the woodchuck animal model for the treatment of hepatitis B virus-induced liver cancer
Manasa Suresh et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B
Nina Le Bert et al.
JOURNAL OF HEPATOLOGY (2020)
The Interactions Between HBV and the Innate Immunity of Hepatocytes
Fayed Attia Koutb Megahed et al.
VIRUSES-BASEL (2020)
A Single and Multiple Ascending Dose Study of Toll-Like Receptor 7 Agonist (RO7020531) in Chinese Healthy Volunteers
Andrea Luk et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection
Nina Le Bert et al.
GASTROENTEROLOGY (2020)
Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection
Zhongji Meng et al.
FRONTIERS IN IMMUNOLOGY (2020)
Diverse Virus and Host-Dependent Mechanisms Influence the Systemic and Intrahepatic Immune Responses in the Woodchuck Model of Hepatitis B
Tomasz I. Michalak
FRONTIERS IN IMMUNOLOGY (2020)
Distinct and Orchestrated Functions of RNA Sensors in Innate Immunity
GuanQun Liu et al.
IMMUNITY (2020)
Efficacy of an Inhibitor of Hepatitis B Virus Expression in Combination With Entecavir and Interferon-α in Woodchucks Chronically Infected With Woodchuck Hepatitis Virus
Stephan Menne et al.
HEPATOLOGY COMMUNICATIONS (2020)
Spontaneous Seroclearance of Hepatitis B Surface Antigen and Risk of Hepatocellular Carcinoma
Ci Song et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Understanding the Natural History of Hepatitis B Virus Infection and the New Definitions of Cure and the Endpoints of Clinical Trials
Alisa Likhitsup et al.
CLINICS IN LIVER DISEASE (2019)
Therapeutic strategies for hepatitis B virus infection: towards a cure
Gregory C. Fanning et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues
Terry Cheuk-Fung Yip et al.
JOURNAL OF HEPATOLOGY (2019)
Innate and adaptive immunity associated with resolution of acute woodchuck hepatitis virus infection in adult woodchucks
Manasa Suresh et al.
PLOS PATHOGENS (2019)
Liver-Targeted Toll-Like Receptor 7 Agonist Combined With Entecavir Promotes a Functional Cure in the Woodchuck Model of Hepatitis B Virus
Kyle E. Korolowizc et al.
HEPATOLOGY COMMUNICATIONS (2019)
Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver
Aleksei Suslov et al.
GASTROENTEROLOGY (2018)
HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon
Pascal Mutz et al.
GASTROENTEROLOGY (2018)
TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues
Carolina Boni et al.
GASTROENTEROLOGY (2018)
Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation
Laura Rivino et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Preclinical mechanistic and efficacy evaluation of a novel small molecule TLR7 agonist RO7020531 for the treatment of chronic hepatitis B
L. Dai et al.
JOURNAL OF HEPATOLOGY (2018)
Combination treatment of a TLR7 agonist RO7020531and a capsid assembly modulator RO7049389 achieved sustainable viral loadsuppression and HBsAg loss in an AAV- HBV mouse model
L. Dai et al.
JOURNAL OF HEPATOLOGY (2018)
Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B
Harry L. A. Janssen et al.
JOURNAL OF HEPATOLOGY (2018)
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B
Darren Wong et al.
LIVER INTERNATIONAL (2018)
Modulators of innate immunity as novel therapeutics for treatment of chronic hepatitis B
Aleksei Suslov et al.
CURRENT OPINION IN VIROLOGY (2018)
Circulating and intrahepatic antiviral B cells are defective in hepatitis B
Alice R. Burton et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Emerging roles of the processing of nucleic acids and Toll-like receptors in innate immune responses to nucleic acids
Kensuke Miyake et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B
Fanny Lebosse et al.
JOURNAL OF HEPATOLOGY (2017)
Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts
Suzanne Faure-Dupuy et al.
VIRUSES-BASEL (2017)
Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA
Yuanjie Liu et al.
PLOS PATHOGENS (2017)
Hepatitis B Virus-Specific and Global T-Cell Dysfunction in Chronic Hepatitis B
Jang-June Park et al.
GASTROENTEROLOGY (2016)
The link between TLR7 signaling and hepatitis B virus infection
Zahra Sepehri et al.
LIFE SCIENCES (2016)
Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B
Kyle E. Korolowicz et al.
PLOS ONE (2016)
Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients
Xiangsheng Xu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
Edward J. Gane et al.
JOURNAL OF HEPATOLOGY (2015)
Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B
Stephan Menne et al.
JOURNAL OF HEPATOLOGY (2015)
Immune Response in Hepatitis B Virus Infection
Anthony Tan et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Dissecting the dendritic cell controversy in chronic hepatitis B virus infection
Adam J. Gehring et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
HBV and the immune response
Carlo Ferrari
LIVER INTERNATIONAL (2015)
Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck
Anna D. Kosinska et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2015)
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
Julie Lucifora et al.
SCIENCE (2014)
Pharmacokinetic and Pharmacodynamic Properties of GS-9620, a Novel Toll-Like Receptor 7 Agonist, Demonstrate Interferon-Stimulated Gene Induction without Detectable Serum Interferon at Low Oral Doses
Abigail Fosdick et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
New insights into how HBV manipulates the innate immune response to establish acute and persistent infection
Peter Revill et al.
ANTIVIRAL THERAPY (2013)
BASIC AND TRANSLATIONAL-LIVER
Robert E. Lanford et al.
GASTROENTEROLOGY (2013)
Hepatitis B Virus Surface Antigen Selectively Inhibits TLR2 Ligand-Induced IL-12 Production in Monocytes/Macrophages by Interfering with JNK Activation
Sen Wang et al.
JOURNAL OF IMMUNOLOGY (2013)
Preserved T-Cell Function in Children and Young Adults With Immune-Tolerant Chronic Hepatitis B
Patrick T. F. Kennedy et al.
GASTROENTEROLOGY (2012)
Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues
Carolina Boni et al.
GASTROENTEROLOGY (2012)
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
Laura Belloni et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Hepatitis B Virus Impairs TLR9 Expression and Function in Plasmacytoid Dendritic Cells
Isabelle E. Vincent et al.
PLOS ONE (2011)
The Hepatitis B Virus X Protein Disrupts Innate Immunity by Downregulating Mitochondrial Antiviral Signaling Protein
Congwen Wei et al.
JOURNAL OF IMMUNOLOGY (2010)
Hepatitis B Virus Suppresses Toll-like Receptor-Mediated Innate Immune Responses in Murine Parenchymal and Nonparenchymal Liver Cells
Jun Wu et al.
HEPATOLOGY (2009)
Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus
Marjoleine L. Op den Brouw et al.
IMMUNOLOGY (2009)
Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection
Stephan Menne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Chemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-Cell responses to pre-S and S regions of the viral envelope protein
Stephan Menne et al.
JOURNAL OF VIROLOGY (2007)
The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection
Stephan Menne et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Regulation of toll-like receptor-2 expression in chronic hepatitis B by the precore protein
Kumar Visvanathan et al.
HEPATOLOGY (2007)
Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type IFN
IB Bekeredjian-Ding et al.
JOURNAL OF IMMUNOLOGY (2005)
Genomic analysis of the host response to hepatitis B virus infection
S Wieland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B
RG van der Molen et al.
HEPATOLOGY (2004)
Hepatocellular carcinoma in the woodchuck mode of hepatitis B virus infection
BC Tennant et al.
GASTROENTEROLOGY (2004)
Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans
XZ Duan et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2004)
Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection
RJ Colonno et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, 1-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax)
SF Peek et al.
HEPATOLOGY (2001)
Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory
J Banatvala et al.
VACCINE (2000)
Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice
SF Wieland et al.
JOURNAL OF VIROLOGY (2000)
Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans
BE Korba et al.
HEPATOLOGY (2000)
分享论文
